The health IT company plans to acquire Vantage Oncology, which provides radiation and medical oncology, and Biologics, an oncology-focused specialty pharmacy.
“These investments will broaden McKesson’s practice management services and solutions that allow oncologists to focus on providing excellent patient care and provide additional support solutions that enhance care delivery for patients,” said John Hammergren, chairman and CEO of McKesson. “We will also be able to offer additional value-added services to our manufacturer partners, expand our reach and pharmaceutical distribution scale, and provide care management and care coordination for payers as the industry moves towards value-based reimbursement models.”
The transactions are subject to customary closing conditions, and McKesson expects the deals to close in the first quarter of fiscal year 2017.
More articles on health IT:
IBM acquires Truven; Epic, Cerner among biggest HIMSS booths; Allscripts, Cerner top hospital customer loyalty — 10 health IT key notes
Internal medicine residents spend 5 hours per day on EHR data entry
5 recent HIPAA settlements
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.